FDANews
www.fdanews.com/articles/87952-debiopharm-aurigene-tie-up-to-develop-selective-compounds-for-immuno-oncology-targets

DEBIOPHARM, AURIGENE TIE UP TO DEVELOP SELECTIVE COMPOUNDS FOR IMMUNO-ONCOLOGY TARGETS

June 28, 2006

The Switzerland-based Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company specialising in oncology and serious medical conditions, and Aurigene Discovery Technologies Ltd (Aurigene), a Bangalore-based discovery services company, signed a research agreement to identify and develop compounds for two innovative immuno-oncology targets. Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=33991ionid)